Humacyte
HUMA
HUMA
70 hedge funds and large institutions have $74M invested in Humacyte in 2022 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 23 increasing their positions, 11 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
15% more funds holding
Funds holding: 61 → 70 (+9)
7% more capital invested
Capital invested by funds: $69M → $74M (+$4.98M)
0.94% more ownership
Funds ownership: 9.25% → 10.18% (+0.94%)
Holders
70
Holding in Top 10
2
Calls
$1.24M
Puts
$932K
Top Buyers
1 | +$8.85M | |
2 | +$3.85M | |
3 | +$2.1M | |
4 |
Millennium Management
New York
|
+$2M |
5 |
BlackRock
New York
|
+$1.25M |
Top Sellers
1 | -$6.53M | |
2 | -$2.9M | |
3 | -$2.18M | |
4 |
UBS Group
Zurich,
Switzerland
|
-$1.75M |
5 |
LPL Financial
San Diego,
California
|
-$1.73M |